CLX
Get informed when a big investor buys or sells
+ FollowOctober 30, 2024 - AI Summary
Undervalued by 92.4% based on the discounted cash flow analysis.
| Market cap | $10.13 Billion |
|---|---|
| Enterprise Value | $15.51 Billion |
| Dividend Yield | $4.97 (5.93%) |
| Earnings per Share | $4.82 |
| Beta | 0.58 |
| Outstanding Shares | 121,775,000 |
| P/E Ratio | 17.39 |
|---|---|
| PEG | -34.15 |
| Price to Sales | 1.54 |
| Price to Book Ratio | 42.49 |
| Enterprise Value to Revenue | 2.31 |
| Enterprise Value to EBIT | 16.62 |
| Enterprise Value to Net Income | 26 |
| Total Debt to Enterprise | 0.36 |
| Debt to Equity | 61.33 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 75.77% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 1.42%▼ 85.12% |
|---|---|
| Total Invested | $139.90M▼ 98.61% |
| Investors Holding | 54▼ 1048.00% |
No data
The Clorox Company (NYSE: CLX) is a leading multinational manufacturer and marketer of consumer and professional products with about 8,800 employees worldwide and fiscal year 2020 sales of $6.7 billion. Clorox markets some of the most tr...